期刊
CANCER IMMUNOLOGY IMMUNOTHERAPY
卷 60, 期 8, 页码 1153-1160出版社
SPRINGER
DOI: 10.1007/s00262-011-1026-2
关键词
Melanoma; T lymphocyte; Immunotherapy; Prognosis; PIVAC 10
Tumor-infiltrating T lymphocytes (TILs) are observed in a number of human primary or metastatic tumors. Recently, gene expression profiling experiments suggested that the presence of T cells in metastatic melanomas before vaccinating the patients with tumor antigens could be a biomarker for clinical benefit from the vaccines. In this context, we review results pertaining to TILs in human melanomas, their prognostic value, and some possible reasons why their presence could help in selecting melanoma patients for vaccination against tumor-specific antigens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据